We’re proud to share that our colleague Pavel Timofeev will be representing TUNECT CRO at CPHI and PMEC China in Shanghai in June! It’s a fantastic opportunity for us to showcase our unwavering commitment to the global clinical development industry and highlight our dedication to international quality standards.

At TUNECT CRO, we are passionate about fine-tuning clinical trials to bring essential medications to market, building trust with our clients and partners worldwide.

What sets us apart is our proven quality, confirmed by numerous submissions to regulatory, such as FDA and European Medicines Agency, with minimal comments on our work. We’re a competitive alternative to the top 10 international CROs, offering the same high standards with stable budgets and no hidden fees thanks to our transparent processes. Plus, we guarantee our quality – any comments from regulatory authorities related to our work will be addressed without additional costs.

We’re looking forward to connecting with many of you at this prestigious event!